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Abstract
Preoperative identification of the risk factors for surgical site infection and patient risk 
stratification are essential for deciding whether surgery is appropriate, educating patients on their 
individual risk of complications, and managing postoperative expectations. Early identification of 
these factors is also necessary to help guide both patient medical optimization and perioperative 
care planning. Several resources are currently available to track and analyze healthcare-associated 
infections, including the Centers for Disease Control and Prevention’s National Healthcare Safety 
Network. In addition, the Centers for Disease Control and Prevention and the American Academy 
of Orthopaedic Surgeons are exploring collaborative opportunities for the codevelopment of a hip 
and/or knee arthroplasty national quality measure for periprosthetic joint infection.
Several risk factors are associated with the development of surgical site infection (SSI) 
following orthopaedic procedures. Preoperative identification of these risk factors and 
patient risk stratification are critical to effectively inform and educate surgical candidates on 
individualized risks (ie, low, intermediate, high), postoperative expectations, and whether 
surgery is appropriate. Furthermore, early recognition of SSI risk factors can prompt specific 
interventions for medical optimization and aid in the development of comprehensive 
perioperative care plans to minimize the risk of SSI. The development of organizations and 
resources to track and analyze healthcare-associated infections (HAIs), including SSIs, has 
aided the establishment of guidelines and standards for management.
Risk Factors
Risk factors for SSI can be categorized as modifiable (eg, Staphylococcus aureus 
colonization, weight) and nonmodifiable (eg, age, sex). Scientific evidence supporting 
practices aimed at reducing the risk of SSI is lacking in some areas, highlighting the 
None of the following authors or any immediate family member has received anything of value from or has stock or stock options held 
in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Florschutz, Dr. Fagan, Dr. Matar, 
Dr. Sawyer, and Dr. Berrios-Torres.
HHS Public Access
Author manuscript
J Am Acad Orthop Surg. Author manuscript; available in PMC 2019 May 23.
Published in final edited form as:
J Am Acad Orthop Surg. 2015 April ; 23(Suppl): S8–S11. doi:10.5435/JAAOS-D-14-00447.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
importance of decisions made and recommendations generated at meetings such as the 
International Consensus Meeting on Periprosthetic Joint Infection (PJI).1
Risk factors can be divided into host and perioperative factors, which can be further divided 
into preoperative, intraoperative, and postoperative factors.2,3 Host optimization has been 
shown to lower the risk of infection and should be started at the initial consultation. 
Preoperative optimization can include glucose and ulcer control in diabetic patients, 
controlling nidi of infections, improving the immune system, and addressing malnutrition 
and obesity.4 Other strategies include optimizing skin condition, improving vascular status, 
smoking cessation, modifying intake of immunosuppressive drugs, and Staphylococcus 
aureus decolonization. A patient history of excessive alcohol consumption, intravenous drug 
use, admission to a healthcare facility, chronic liver disease, or chronic renal failure is also 
known to increase the risk of SSI.
Several perioperative strategies are aimed at reducing the risk of SSI. The goal of skin 
preparation steps (eg, preoperative showering or bathing, hair removal, and intra-operative 
antiseptic skin preparation) is to reduce the skin bacterial counts. Chlorhexidine gluconate 
whole-body showering the night before surgery is commonly recommended; however, it has 
not been shown to lower the risk of SSI.5–7 Hair removal by clipping (not shaving) at the 
time of surgery has been shown to lower the risk of SSI.8 There is no clear scientific 
evidence regarding the optimal antiseptic skin preparation solution; however, some studies 
indicate that the use of an alcohol-based agent improves the elimination of skin flora 
compared with the use of aqueous solutions.9,10 Antimicrobial prophylaxis with cefazolin is 
a common choice in orthopaedic procedures because this agent has excellent in vivo activity 
against common gram-positive and certain gramnegative aerobes (eg, Escherichia coli, 
Klebsiella species), long half-life, and good tissue penetration. In a systemic review and 
meta-analysis of seven studies, AlBuhairan et al11 found that antimicrobial prophylaxis 
reduced the absolute risk of SSI associated with total joint arthroplasty by 8%. Vancomycin 
should not be used routinely as a surgical antimicrobial prophylactic agent. However, in 
patients with a cephalosporin allergy or in those who test positive for methicillin-resistant 
Staphylococcus aureus, clindamycin or vancomycin combined with an aminoglycoside (for 
gram-negative coverage) may be used in place of cefazolin.
Intraoperatively, the use of laminar flow and body exhaust suits in total joint arthroplasty is 
common; however, both of these strategies, which are aimed at lowering surgical site 
contamination, have conflicting support in the literature.12–14 A systematic study in the 
1970s (that has not been challenged since then) established that operating room (OR) 
personnel are the primary source of bacteria in the OR; therefore, limiting traffic is essential.
15
 Although the evidence is limited, frequent glove changes after draping and during long 
cases could also be considered because of high contamination rates and puncture rates.16 
The optimal wound irrigation method and content of the irrigation solution remain 
controversial, whereas the use of antibiotic-laden cement has been shown to be cost-effective 
and associated with a lower risk of PJI.17 Longer OR times have been associated with an 
increased risk of PJI, and the use of strategies aimed at improving efficiency with dedicated 
OR teams should be considered.18
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Wound optimization for healing should be sought in all cases with the use of meticulous 
closure techniques, sealed dressings, infrequent dressing changes, and close observation.19 
During the postoperative period, hematoma formation has been shown to be associated with 
the use of certain anticoagulation agents as well as an increased risk of PJI.20 Persistent 
wound drainage has also been associated with a greater risk of PJI compared with incisions 
that heal normally.21,22 Therefore, persistent postoperative drainage should be promptly 
assessed (eg, serum erythrocyte sedimentation rate, C-reactive protein, interleukin-6, 
aspiration) and closely followed, maintaining a low threshold to proceed with surgical 
débridement as appropriate.
The American College of Surgeons and National Surgical Quality 
Improvement Program Risk Calculator
The American College of Surgeons has developed a risk calculator to assist surgeons, 
patients, and families in understanding the risks of major complications after surgical 
procedures. This calculator uses data collected from hundreds of thousands of patients 
through the National Surgical Quality Improvement Program.23 This risk calculator can be 
used to estimate the chance of an unfavorable surgical outcome. Risk is estimated using 
information on prior health history provided by the patient. Data from a large number of 
patients who had a similar surgical procedure are then used to estimate the risk of 
complications.
The risk calculator is available for free online. Data include procedure, sex, age, certain 
elements of the medical history, functional status, American Society of Anesthesiologists 
Physical Status Classification System, wound classification, case urgency, height and weight 
(to allow the calculation of body mass index), and the presence of sepsis. With these data, 
the risks of developing the following complications are displayed: serious complications, 
any complication, pneumonia, cardiac complication, SSI, urinary tract infection, venous 
thromboembolism, renal failure, return to the OR, death, and discharge to nursing or 
rehabilitation facility. In addition, the predicted length of stay can be estimated, as well. The 
surgeon is then able to slightly modify the output if he or she thinks the patient is at either 
slightly higher or lower risk based on other elements of the medical history not captured 
with the standard data input.
The risk calculator is available for arthroplasty, spine procedures, arthroscopy, and many 
other major orthopaedic procedures. For example, the estimated risk of SSI in a 70-year-old 
woman with type I diabetes mellitus and hypertension who is undergoing a total knee 
arthroplasty is 0.6%. This resource could readily be incorporated immediately into clinical 
practice to help patients and surgeons make better informed choices.
National Healthcare Safety Network
The National Healthcare Safety Network (NHSN) is a secure, internet-based surveillance 
system that was established by the Division of Healthcare Quality Promotion at the Centers 
for Disease Control and Prevention (CDC) in 2005, and it is used by the CDC, healthcare 
facilities, state health departments, and other agencies and organizations to track HAIs, 
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including SSIs.24–28 As of 2012, 2,130 facilities in 48 states and Washington, DC reported 
SSI data for at least one type of surgical procedure (Cathy Rebmann, NHSN, personal 
communication, April 2014).25 In 17 states, the legislature or health department requires 
reporting of SSI associated with hip and/or knee arthroplasty procedures (Cathy Rebmann, 
NHSN, personal communication, April 2014). The CDC and the American Academy of 
Orthopaedic Surgeons (AAOS) are collaborating to improve NHSN risk modeling for hip 
and knee arthroplasty, and both organizations are considering codevelopment of clinical 
quality measure proposals for SSIs following these procedures.
NHSN Surveillance Definitions
A working group of the federal Healthcare Infection Control Practices Advisory Committee 
(HICPAC) completed a comprehensive review of NHSN SSI definitions in 2011 and 2012. 
Representatives from the AAOS and the Musculoskeletal Infection Society as well as other 
subject matter experts provided input. The HICPAC working group supported NHSN 
adoption of the International Consensus Meeting on PJI’s definition of PJI as the hip and 
knee arthroplasty “organ/space” SSI (PJI).1,29
NHSN Risk Modeling
Since 2012, the Centers for Medicare and Medicaid Services (CMS) rulemaking, authorized 
by the Healthcare and Education Affordability Reconciliation Act of 2010,30 has required 
that all Inpatient Prospective Payment System healthcare facilities participating in the CMS 
Inpatient Quality Reporting program report their SSI data for colon and abdominal 
hysterectomy procedures to NHSN, as outlined in the US Department of Health and Human 
Services Action Plan to Prevent Healthcare Associated Infections.25,31 NHSN reports 
facility-level HAI data on behalf of hospitals to CMS using the standardized infection ratio 
(SIR) as the summary measure.32 The SIR is the ratio of the number of SSIs reported to the 
number of SSIs predicted.25,33–35 In calculating the SIR, the predicted number of SSIs is 
based on the procedure-specific, patient-level risk factors.
Current risk factor variables in the NHSN hip and knee arthroplasty risk model include age, 
American Society for Anesthesiologists Physical Status Classification score, procedure 
duration, trauma, hospital bed size and teaching status, primary versus revision arthroplasty, 
and total hip arthroplasty versus hemiarthroplasty.36 At the recommendation of the HICPAC 
working group, NHSN began collecting patient height, weight, and diabetic status for all 
procedure types in 2014. Additionally, a new variable to identify revision hip and knee 
arthroplasties that are associated with prior infection at the index joint is scheduled to be 
added in 2015. The NHSN and AAOS are working to develop reporting specifications for 
this new variable and to better define International Classification of Disease, ninth revision 
(and eventually the 10th revision), clinical modification mappings to denominator-procedure 
characteristics (eg, revision, primary, resurfacing). These new variables will be considered 
when NHSN risk models are updated, which is tentatively planned for 2016 using 2015 data.
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Proposed Development of Prosthetic Joint Arthroplasty Quality Measure
As mentioned previously, the CDC and AAOS are exploring collaborative opportunities to 
develop a hip and/or knee arthroplasty PJI quality measure. The goal would be to achieve 
consensus on reporting definitions, including surgical procedures, and risk adjustment that 
would be mutually agreeable to both organizations. The initial step is to work on refining the 
NHSN risk adjustment for PJI. The ultimate goal is to gain National Quality Forum 
endorsement of a national PJI measure.37
Summary
Early evaluation of perioperative SSI risk factors and patient risk stratification could be of 
great value in the development of predictive risk models. Predictive risk models could, in 
turn, assist surgeons and their patients in the clinical decision-making process (eg, 
counseling patients on the appropriateness and risks of surgery). In addition, risk models 
could be used to develop targeted perioperative prevention strategies and diagnostic care 
process models and improve risk adjustment for risk modeling used in the public reporting 
of SSI as a quality metric.38,39 However, development of these models is challenging.
Risk factor data collection is commonly performed through a manual review of patient 
medical records or through electronic mining of administrative data. There is a critical need 
to reduce the data collection burden by making better use of existing electronic medical 
record systems in the capture of risk factor data. Furthermore, there is a need to evaluate 
current barriers to the use of Current Procedural Terminology codes, whose granularity 
might be more useful for SSI surveillance purposes.
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